Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients.

Journal of viral hepatitis - 1 Aug 2015

Chowdhury S J, Karra V K, Bharali R, Kar P

Abstract excerpt

The basis of hepatitis C virus (HCV) evasion of immune system and its response to treatment is still elusive. There have been studies where the level of C4 has been found to be associated with HCV persistence and disease progression. This study aims to find out relationship between levels of C4 in serum, and its functional SNPs with response to treatment. The study included 84 patients with CHC who received...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Antiviral Agents
Share to Complement C4

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Enzyme-Linked Immunosorbent Assay

Share to Genotyping Techniques

Share to Hepatitis C, Chronic

Share to Real-Time Polymerase Chain Reaction

Source

Identifiers

PMID: 25573496
DOI: 10.1111/jvh.12383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients.PMID 25573496Read ↗

rs2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis C patients.Semantic proximity Read ↗

Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects.Semantic proximity Read ↗

Causal Association between Circulating Complement Components and Non-Viral Liver Diseases and Their Potential as Therapeutic Targets: An Integrated Analysis Based on Multi-omics DataSemantic proximity Read ↗

Two sides of a coin: GG genotype of C7 provides protection against fibrosis severity while showing a higher risk for hepatocellular carcinoma in patients with hepatitis C.Semantic proximity Read ↗

Role of fluid-phase complement system regulation in the development of hepatitis C virus-associated glomerulonephritis.Semantic proximity Read ↗

Prediction of Fibrosis Progression Rate in Patients with Chronic Hepatitis C Genotype 4: Role of Cirrhosis Risk Score and Host Factors.Semantic proximity Read ↗

A Multi-Biomarker Prediction Model Integrating Genetics, Hematological Indices, and Fibrosis Stage to Forecast Non-Response in HCV Genotype 4Semantic proximity Read ↗

Transcriptional Repression of C4 Complement by Hepatitis C Virus ProteinsSemantic proximity Read ↗

Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma.Semantic proximity Read ↗

Interaction networks of hepatitis C virus NS4B: implications for antiviral therapySemantic proximity Read ↗

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targetsSemantic proximity Read ↗

Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.